Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case–control study using Cerner Real-World Data
Tallon EM*, Gallagher MP*, Staggs VS, Ferro D, Murthy DB, Ebekozien O, Kosiborod MN, Lind M, Manrique-Acevedo C, Shyu CR,…
Diabetic ketoacidosis rates rose among patients with type 1 diabetes during U.S. COVID-19 peaks with highest burden on non-Hispanic Blacks
A.R. Lavik1, N.-H. Yayah Jones1, S. Rompicherla2, M. Greenfield3, J. Chen3, S. Polsky4, G.T. Alonso4, S. Corathers1, S. Blackman5, M.P….
Factors associated with hospitalization in youths and young adults with type 2 diabetes and COVID-19 infection
E. Tallon1, O. Ebekozien2,3, J. Sanchez4, V. Staggs5,6, D. Ferro5, C.-R. Shyu1, M. Clements5 1University of Missouri-Columbia, Institute for Data…
Factors associated with hospitalization in youths and young adults with type 1 diabetes and COVID-19 infection
E. Tallon1, O. Ebekozien2,3, J. Sanchez4, V. Staggs5,6, D. Ferro5, C.-R. Shyu1, M. Clements5 1University of Missouri-Columbia, Institute for Data…
Increase in newly diagnosed type 1 diabetes among pediatric and adolescent patients during the COVID-19 pandemic in the United States: A multi-center analysis
R.M Wolf1, N. Noor2, R. Izquierdo3, D. Jett3, A. Rewers4, S. Majidi4, N. Sheanon5, E. Breidbart6, C. Demeterco-Berggren7, J.M Lee8,…
Strong association between health insurance type and adverse outcomes for pediatric and adolescent patients with type 1 diabetes and COVID-19; Data from the T1D Exchange COVID Registry
S. Rompicherla1, N. Noor1, A. Kim2, G. Nelson2, O. Odugbesan1, N. Rioles1, A. Mungmode1, J. Sarhis3, A. Roberts4, O. Osagie…
Health Outcomes in COVID-19 Positive Patients with T1D Using an Insulin Pump
Background and Aims: The use of continuous subcutaneous insulin infusion (CSII) has demonstrated fewer acute complications in patients with type 1…
CGM Usage and Health Outcomes among People with T1D and COVID-19
Background and Aims: Continuous glucose monitoring (CGM) improves glycemic control and reduces complications in patients with type 1 diabetes (T1D). This…
Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic.
Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative…
Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes.
We commend Gregory and colleagues for their well-designed prospective study to quantify and contextualize the risk for coronavirus disease 2019…